[
  {
    "title": "Global Immune Checkpoint Inhibitors Market 2020-2025 - Increased Adoption of pembrolizumab (KEYTRUDA), The First PD-1 Inhibitor Since it's Approval in 2014 - PRNewswire",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Global Immune Checkpoint Inhibitors Market 2020-2025 - Increased Adoption of pembrolizumab (KEYTRUDA), The First PD-1 Inhibitor Since it's Approval in 2014 - PRNewswire"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.prnewswire.com/news-releases/global-immune-checkpoint-inhibitors-market-2020-2025---increased-adoption-of-pembrolizumab-keytruda-the-first-pd-1-inhibitor-since-its-approval-in-2014-301169886.html"
      }
    ],
    "link": "https://www.prnewswire.com/news-releases/global-immune-checkpoint-inhibitors-market-2020-2025---increased-adoption-of-pembrolizumab-keytruda-the-first-pd-1-inhibitor-since-its-approval-in-2014-301169886.html",
    "id": "CBMizwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2dsb2JhbC1pbW11bmUtY2hlY2twb2ludC1pbmhpYml0b3JzLW1hcmtldC0yMDIwLTIwMjUtLS1pbmNyZWFzZWQtYWRvcHRpb24tb2YtcGVtYnJvbGl6dW1hYi1rZXl0cnVkYS10aGUtZmlyc3QtcGQtMS1pbmhpYml0b3Itc2luY2UtaXRzLWFwcHJvdmFsLWluLTIwMTQtMzAxMTY5ODg2Lmh0bWzSAQA",
    "guidislink": false,
    "published": "Tue, 10 Nov 2020 18:15:00 GMT",
    "published_parsed": [
      2020,
      11,
      10,
      18,
      15,
      0,
      1,
      315,
      0
    ],
    "summary": "<a href=\"https://www.prnewswire.com/news-releases/global-immune-checkpoint-inhibitors-market-2020-2025---increased-adoption-of-pembrolizumab-keytruda-the-first-pd-1-inhibitor-since-its-approval-in-2014-301169886.html\" target=\"_blank\">Global Immune Checkpoint Inhibitors Market 2020-2025 - Increased Adoption of pembrolizumab (KEYTRUDA), The First PD-1 Inhibitor Since it's Approval in 2014</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PRNewswire</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.prnewswire.com/news-releases/global-immune-checkpoint-inhibitors-market-2020-2025---increased-adoption-of-pembrolizumab-keytruda-the-first-pd-1-inhibitor-since-its-approval-in-2014-301169886.html\" target=\"_blank\">Global Immune Checkpoint Inhibitors Market 2020-2025 - Increased Adoption of pembrolizumab (KEYTRUDA), The First PD-1 Inhibitor Since it's Approval in 2014</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PRNewswire</font>"
    },
    "source": {
      "href": "https://www.prnewswire.com",
      "title": "PRNewswire"
    },
    "sub_articles": []
  }
]